SCHEMBL104240

SCHEMBL104240

CC=CC(=O)NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL295221 1.00
SCHEMBL4559860 1.00
Hydrochloric Acid SCHEMBL29486040 0.97
SCHEMBL1630764 0.83 CHRNB2 (0.44)
SCHEMBL1630761 0.83 CHRNB2 (0.44)
SCHEMBL2486077 0.83 CHRNB2 (0.44)
SCHEMBL10054192 0.80
SCHEMBL22881957 0.80
SCHEMBL26001868 0.78 CHRNB2 (0.31)
SCHEMBL11706114 0.78 ALDH1A1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119920847-A Pole piece, preparation method thereof, diaphragm-free battery and solid-state battery 重庆太蓝新能源有限公司 2025-05-02 CN claimed
CN-112739695-B Novel thiazole derivative and pharmaceutically acceptable salt thereof 永进药品工业株式会社 2025-03-18 CN claimed
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 EP claimed
EP-3853225-B1 N-(5-(3-(1-((THIAZOL-2-YL)AMINO)-1-OXOPROPAN-2-YL)PHENYL)PYRIDIN-2-YL)ACRYLAMIDE DERIVATIVES AS CDK7 INHIBITORS FOR THE TREATMENT OF CANCER YUNGJIN PHARMACEUTICAL CO LTD (KR) 2023-11-29 EP claimed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 WO claimed
CN-116359401-B Method for simultaneously measuring five impurities in levocarnitine by high performance liquid chromatography 山东齐都药业有限公司 2023-08-22 CN claimed
CN-115485274-A Pharmaceutical composition for preventing or treating cancer comprising thiazole derivative or pharmaceutically acceptable salt thereof 永进药品株式会社 2022-12-16 CN claimed
EP-2216351-B2 Water-swellable copolymers and articles and coating made therefrom COVIDIEN LP (US) 2016-05-18 EP claimed
US-9096598-B2 Azaindoles as Janus kinase inhibitors MERCK SHARP & DOHME CORP. (US) 2015-08-04 US claimed
EP-4720038-A1 (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES Neophore Limited (GB) 2026-04-08 EP disclosed
US-12384172-B2 Ink jet recording method and ink jet recording apparatus CANON KABUSHIKI KAISHA (JP) 2025-08-12 US disclosed
CN-112739695-B Novel thiazole derivative and pharmaceutically acceptable salt thereof 永进药品工业株式会社 2025-03-18 CN disclosed
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 EP disclosed
US-20250032448-A1 COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES KOH, Hwee Ling (SG) 2025-01-30 US disclosed
EP-0400865-A1 Improved viscosity stable multifunctional viscosity index modifier additives derived from amido amines EXXON CHEMICAL PATENTS INC. (US) 1990-12-05 EP disclosed
EP-0012320-A1 Thionophosphonic acid esters, process for preparing them and their use as pesticides BASF Aktiengesellschaft (DE) 1980-06-25 EP disclosed
US-4209446-A FROM PIPERONAL AND A CROTONIC AMIDE IN PRESENCE OF ALKALI METAL HYDROXIDE AND DIPOLAR APROTIC DILUENT HAARMAN & REIMER GMBH (DE) 1980-06-24 US disclosed
US-4209445-A FROM PIPERONAL AND A CROTONIC AMIDE IN PRESENCE OF QUATERNARY AMMONIUM OR PHOSPHONIUM HYDROXIDE OR CROWN ETHER METAL COMPLEX HAARMAN & REIMER GMBH (DE) 1980-06-24 US disclosed
US-4144388-A Film-forming and thermocurable vinyl alcohol-substituted acrylamide copolymers and process for production thereof MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1979-03-13 US disclosed
US-4107418-A OF AN ACRYLIC MONOMER AND ANOTHER UNSATURATED MONOMER; CATALYST COMPRISING AN ORGANOALUMINUM HALIDE AND ORGANIC PEROXIDE MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) 1978-08-15 US disclosed